+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Esters Anesthetic Market by Product Formulation, Mechanism of Action, Clinical Application, Patient Demographics, Healthcare Setting, Procedure Complexity, Safety Profile, Chemical Properties - Global Forecast to 2030- Product Image
Esters Anesthetic Market by Product Formulation, Mechanism of Action, Clinical Application, Patient Demographics, Healthcare Setting, Procedure Complexity, Safety Profile, Chemical Properties - Global Forecast to 2030- Product Image
Sale

Esters Anesthetic Market by Product Formulation, Mechanism of Action, Clinical Application, Patient Demographics, Healthcare Setting, Procedure Complexity, Safety Profile, Chemical Properties - Global Forecast to 2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6160935
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The global esters anesthetic sector is witnessing pivotal growth driven by advancements in formulation science, evolving regulatory frameworks, and heightened demand for safer, more efficient patient care. Esters-based local anesthetics, known for rapid onset and favorable biotransformation profiles, are increasingly preferred in diverse clinical settings ranging from minor dermatological interventions to complex surgical procedures. This executive summary distills the most critical market dynamics, transformative shifts, tariff impacts, segmentation nuances, regional insights, leading competitor activities, and strategic recommendations necessary for stakeholders to navigate the evolving landscape with confidence and precision.

Transformative Shifts Redefining the Esters Anesthetic Landscape

Recent years have ushered in transformative shifts across the esters anesthetic landscape, prompted by a confluence of technological breakthroughs, patient-centric care models, and regulatory recalibrations. Nanocarrier-enabled topical delivery systems are redefining transdermal patch efficacy, while real-time pharmacokinetic monitoring tools enhance intravenous administration precision. Concurrently, guidelines from major health authorities are emphasizing safety profiling and adverse reaction minimization, compelling manufacturers to innovate mechanisms of action such as voltage-dependent and use-dependent sodium channel inhibition. The rise of telehealth consultations has extended demand for ambulatory surgery center applications, reinforcing the need for versatile formulations. As personalized medicine trends accelerate, customizable ester blends tailored to individual metabolism rates and half-life requirements are setting new standards in procedural anesthesia.

Cumulative Impact of United States Tariffs 2025 on Esters Anesthetic

The implementation of United States tariffs in 2025 has imposed a cumulative strain on the esters anesthetic supply chain, prompting manufacturers to reassess global sourcing and production footprints. Import duties on key raw chemical intermediates have elevated material costs by approximately 8-12%, compelling some producers to repatriate manufacturing or secure alternative suppliers in tariff-exempt jurisdictions. Simultaneously, downstream packaging and distribution expenses have increased due to higher logistics surcharges on finished formulations. These cost escalations have been absorbed variably: larger enterprises leveraged scale to mitigate margin erosion, whereas smaller innovators have pursued strategic alliances with contract development organizations in countries with preferential trade agreements. Ultimately, the tariff framework has reshaped pricing strategies, incentivized forward-contract hedging, and accelerated supply diversification to safeguard product availability.

Key Segmentation Insights Driving Market Differentiation

Market differentiation in esters anesthetic is illuminated by a multi-dimensional segmentation approach. Based on product formulation, stakeholders evaluate injectable solutions alongside intravenous infusions, topical gels, and transdermal patch delivery systems. Mechanism of action segmentation contrasts ion channel blockade technologies with reversible inhibition platforms and a specialized focus on sodium channel inhibition, delineating between use-dependent and voltage-dependent modalities. Clinical applications span dental procedures-from localized dental work to oral surgery-through dermatological applications, diagnostic interventions, minor surgeries, and ophthalmic uses. Patient demographics inform targeted formulations for adult populations, further distinguished into female and male adults, as well as geriatrics, pediatrics, and infants. Healthcare settings range from academic institutions and ambulatory surgery centers to hospitals and private clinics. Procedural complexity segmentation covers emergency interventions, major operations, and minor treatments, while safety profile considerations address adverse reactions, allergic responses, long-term effects, and toxicity thresholds. Finally, chemical property analysis examines biodegradability, metabolic rate, solubility parameters, half-life stability, and overall molecular integrity under clinical handling conditions.

Regional Insights Shaping Global Market Dynamics

Regional market dynamics for esters anesthetic reveal distinct growth trajectories across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, rising investments in ambulatory surgery infrastructure and favorable reimbursement frameworks are fueling adoption of advanced injectable and transdermal patch systems. The Europe, Middle East & Africa region is characterized by heterogeneous regulatory landscapes that both challenge and catalyze innovation in reversible inhibition and sodium channel blockade products, with particular momentum in clinical trial activity across the Gulf Cooperation Council. Asia-Pacific exhibits rapid expansion owing to burgeoning private clinic networks, rising healthcare expenditure, and a youthful patient demographic driving demand for minimally invasive topical formulations. Collectively, these regional insights underscore the importance of localized market strategies and regulatory agility to capture emerging opportunities.

Competitive Analysis: Leading Players in Esters Anesthetic

Competitive intensity in the esters anesthetic domain is underscored by a roster of established players and agile innovators. 3M Company’s Medical Division leverages its materials science expertise to optimize patch adhesion and release kinetics. Abbott Laboratories continues to refine intravenous formulations with enhanced pharmacokinetic profiles. AstraZeneca plc explores novel ester derivatives aimed at reducing systemic metabolism variability. Baxter International Inc. and Bayer AG maintain robust portfolios spanning safety data analytics and allergic response mitigation. Becton Dickinson and Company and Boston Scientific Corporation integrate device-drug combination solutions for precise delivery. Cardinal Health, Inc. and CSL Limited enhance cold chain logistics for injectable stability. Drägerwerk AG & Co. KGaA and Edwards Lifesciences Corporation invest in anesthesia monitoring platforms that interface seamlessly with ester-based infusions. Eli Lilly and Company and GE Healthcare are advancing real-time dosing algorithms, while GlaxoSmithKline plc and Johnson & Johnson focus on broadening clinical application indications. Medtronic plc and Merck & Co. pursue partnerships to co-develop reversible inhibition compounds. Mindray Medical International Limited and Olympus Corporation’s Medical Division are scaling device adaptation for topical administration. Pfizer Inc. and Philips Healthcare incorporate AI-driven safety profiling into ester anesthetic workflows. Regeneron Pharmaceuticals, Inc. and ResMed Inc. prioritize allergy profiling and chronic condition integration. Roche Holding AG and Sanofi S.A. adopt molecular stability platforms to extend shelf life. Siemens Healthineers, Stryker Corporation, Terumo Corporation, and Zimmer Biomet Holdings, Inc. expand their product ecosystems through targeted acquisitions and global distribution alliances.

Actionable Recommendations for Industry Leaders

Industry leaders must embrace a multifaceted strategy to sustain competitive advantage: prioritize investment in modular transdermal platforms to meet growing demand for non-invasive delivery, integrate advanced analytics for safety profile optimization across adverse reaction and toxicity data, and foster strategic partnerships with contract development organizations to circumvent tariff-driven cost inflation. Additionally, aligning product pipelines with evolving reimbursement policies in key regions and leveraging emerging telehealth channels for decentralized clinical trials will enhance market responsiveness. A dedicated focus on chemical property engineering-optimizing biodegradability, solubility, and half-life-will differentiate next-generation formulations, while agile supply chain models anchored by diversified sourcing will mitigate geopolitical risks.

Conclusion: Strategic Outlook for Esters Anesthetic

The esters anesthetic market stands at a critical juncture where technological innovation, regulatory evolution, and shifting patient expectations converge. Strategic imperatives include harnessing novel formulation science, anticipating tariff-induced supply chain adjustments, and tailoring segmented offerings to distinct clinical applications and patient demographics. By synthesizing these insights, stakeholders can allocate resources effectively, expedite go-to-market timelines, and enhance therapeutic outcomes. The convergence of personalized anesthetic regimens and robust safety profiling promises to redefine standards of care, positioning early adopters for sustained leadership in an increasingly complex and dynamic market.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Formulation
    • Injectable
    • Intravenous
    • Topical
    • Transdermal
      • Patch
  • Mechanism Of Action
    • Ion Channel Blockade
    • Reversible Inhibition
    • Sodium Channel Inhibition
      • Use Dependent
      • Voltage Dependent
  • Clinical Application
    • Dental Procedures
      • Local Dental
      • Oral Surgery
    • Dermatological Procedures
    • Diagnostic Procedures
    • Minor Surgery
    • Ophthalmic Procedures
  • Patient Demographics
    • Adults
      • Female Adults
      • Male Adults
    • Geriatrics
    • Infants
    • Pediatrics
  • Healthcare Setting
    • Academic Institution
    • Ambulatory Surgery Center
    • Hospital
    • Private Clinic
  • Procedure Complexity
    • Emergency Procedures
    • Major Procedures
    • Minor Procedures
  • Safety Profile
    • Adverse Reactions
    • Allergic Responses
    • Long Term Effects
    • Toxicity
  • Chemical Properties
    • Biodegradability
    • Half Life
    • Metabolism Rate
    • Solubility
    • Stability
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • 3M Company (Medical Division)
  • Abbott Laboratories
  • AstraZeneca plc
  • Baxter International Inc.
  • Bayer AG
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • CSL Limited
  • Drägerwerk AG & Co. KGaA
  • Edwards Lifesciences Corporation
  • Eli Lilly and Company
  • GE Healthcare
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Medtronic plc
  • Merck & Co.
  • Mindray Medical International Limited
  • Novartis International AG
  • Olympus Corporation (Medical Division)
  • Pfizer Inc.
  • Philips Healthcare (Royal Philips)
  • Regeneron Pharmaceuticals, Inc.
  • ResMed Inc.
  • Roche Holding AG
  • Sanofi S.A.
  • Siemens Healthineers
  • Stryker Corporation
  • Terumo Corporation
  • Zimmer Biomet Holdings, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Esters Anesthetic Market, by Product Formulation
8.1. Introduction
8.2. Injectable
8.3. Intravenous
8.4. Topical
8.5. Transdermal
8.5.1. Patch
9. Esters Anesthetic Market, by Mechanism Of Action
9.1. Introduction
9.2. Ion Channel Blockade
9.3. Reversible Inhibition
9.4. Sodium Channel Inhibition
9.4.1. Use Dependent
9.4.2. Voltage Dependent
10. Esters Anesthetic Market, by Clinical Application
10.1. Introduction
10.2. Dental Procedures
10.2.1. Local Dental
10.2.2. Oral Surgery
10.3. Dermatological Procedures
10.4. Diagnostic Procedures
10.5. Minor Surgery
10.6. Ophthalmic Procedures
11. Esters Anesthetic Market, by Patient Demographics
11.1. Introduction
11.2. Adults
11.2.1. Female Adults
11.2.2. Male Adults
11.3. Geriatrics
11.4. Infants
11.5. Pediatrics
12. Esters Anesthetic Market, by Healthcare Setting
12.1. Introduction
12.2. Academic Institution
12.3. Ambulatory Surgery Center
12.4. Hospital
12.5. Private Clinic
13. Esters Anesthetic Market, by Procedure Complexity
13.1. Introduction
13.2. Emergency Procedures
13.3. Major Procedures
13.4. Minor Procedures
14. Esters Anesthetic Market, by Safety Profile
14.1. Introduction
14.2. Adverse Reactions
14.3. Allergic Responses
14.4. Long Term Effects
14.5. Toxicity
15. Esters Anesthetic Market, by Chemical Properties
15.1. Introduction
15.2. Biodegradability
15.3. Half Life
15.4. Metabolism Rate
15.5. Solubility
15.6. Stability
16. Americas Esters Anesthetic Market
16.1. Introduction
16.2. Argentina
16.3. Brazil
16.4. Canada
16.5. Mexico
16.6. United States
17. Asia-Pacific Esters Anesthetic Market
17.1. Introduction
17.2. Australia
17.3. China
17.4. India
17.5. Indonesia
17.6. Japan
17.7. Malaysia
17.8. Philippines
17.9. Singapore
17.10. South Korea
17.11. Taiwan
17.12. Thailand
17.13. Vietnam
18. Europe, Middle East & Africa Esters Anesthetic Market
18.1. Introduction
18.2. Denmark
18.3. Egypt
18.4. Finland
18.5. France
18.6. Germany
18.7. Israel
18.8. Italy
18.9. Netherlands
18.10. Nigeria
18.11. Norway
18.12. Poland
18.13. Qatar
18.14. Russia
18.15. Saudi Arabia
18.16. South Africa
18.17. Spain
18.18. Sweden
18.19. Switzerland
18.20. Turkey
18.21. United Arab Emirates
18.22. United Kingdom
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. 3M Company (Medical Division)
19.3.2. Abbott Laboratories
19.3.3. AstraZeneca plc
19.3.4. Baxter International Inc.
19.3.5. Bayer AG
19.3.6. Becton Dickinson and Company
19.3.7. Boston Scientific Corporation
19.3.8. Cardinal Health, Inc.
19.3.9. CSL Limited
19.3.10. Drägerwerk AG & Co. KGaA
19.3.11. Edwards Lifesciences Corporation
19.3.12. Eli Lilly and Company
19.3.13. GE Healthcare
19.3.14. GlaxoSmithKline plc
19.3.15. Johnson & Johnson
19.3.16. Medtronic plc
19.3.17. Merck & Co.
19.3.18. Mindray Medical International Limited
19.3.19. Novartis International AG
19.3.20. Olympus Corporation (Medical Division)
19.3.21. Pfizer Inc.
19.3.22. Philips Healthcare (Royal Philips)
19.3.23. Regeneron Pharmaceuticals, Inc.
19.3.24. ResMed Inc.
19.3.25. Roche Holding AG
19.3.26. Sanofi S.A.
19.3.27. Siemens Healthineers
19.3.28. Stryker Corporation
19.3.29. Terumo Corporation
19.3.30. Zimmer Biomet Holdings, Inc.
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. ESTERS ANESTHETIC MARKET MULTI-CURRENCY
FIGURE 2. ESTERS ANESTHETIC MARKET MULTI-LANGUAGE
FIGURE 3. ESTERS ANESTHETIC MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ESTERS ANESTHETIC MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2024 VS 2030 (%)
FIGURE 18. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY CHEMICAL PROPERTIES, 2024 VS 2030 (%)
FIGURE 22. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY CHEMICAL PROPERTIES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS ESTERS ANESTHETIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS ESTERS ANESTHETIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES ESTERS ANESTHETIC MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES ESTERS ANESTHETIC MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC ESTERS ANESTHETIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC ESTERS ANESTHETIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA ESTERS ANESTHETIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. EUROPE, MIDDLE EAST & AFRICA ESTERS ANESTHETIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. ESTERS ANESTHETIC MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. ESTERS ANESTHETIC MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ESTERS ANESTHETIC MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ESTERS ANESTHETIC MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY ION CHANNEL BLOCKADE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY REVERSIBLE INHIBITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY SODIUM CHANNEL INHIBITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY USE DEPENDENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY VOLTAGE DEPENDENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY SODIUM CHANNEL INHIBITION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY DENTAL PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY LOCAL DENTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY ORAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY DENTAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY DERMATOLOGICAL PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY MINOR SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY OPHTHALMIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY FEMALE ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY MALE ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY INFANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY ACADEMIC INSTITUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY PRIVATE CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY EMERGENCY PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY MAJOR PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY MINOR PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY ADVERSE REACTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY ALLERGIC RESPONSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY LONG TERM EFFECTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY TOXICITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY CHEMICAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY BIODEGRADABILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY HALF LIFE, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY METABOLISM RATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY SOLUBILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL ESTERS ANESTHETIC MARKET SIZE, BY STABILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS ESTERS ANESTHETIC MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS ESTERS ANESTHETIC MARKET SIZE, BY SODIUM CHANNEL INHIBITION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS ESTERS ANESTHETIC MARKET SIZE, BY DENTAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS ESTERS ANESTHETIC MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS ESTERS ANESTHETIC MARKET SIZE, BY CHEMICAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS ESTERS ANESTHETIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA ESTERS ANESTHETIC MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA ESTERS ANESTHETIC MARKET SIZE, BY SODIUM CHANNEL INHIBITION, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA ESTERS ANESTHETIC MARKET SIZE, BY DENTAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA ESTERS ANESTHETIC MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA ESTERS ANESTHETIC MARKET SIZE, BY CHEMICAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL ESTERS ANESTHETIC MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL ESTERS ANESTHETIC MARKET SIZE, BY SODIUM CHANNEL INHIBITION, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL ESTERS ANESTHETIC MARKET SIZE, BY DENTAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL ESTERS ANESTHETIC MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL ESTERS ANESTHETIC MARKET SIZE, BY CHEMICAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 94. CANADA ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 95. CANADA ESTERS ANESTHETIC MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 96. CANADA ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 97. CANADA ESTERS ANESTHETIC MARKET SIZE, BY SODIUM CHANNEL INHIBITION, 2018-2030 (USD MILLION)
TABLE 98. CANADA ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. CANADA ESTERS ANESTHETIC MARKET SIZE, BY DENTAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 100. CANADA ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 101. CANADA ESTERS ANESTHETIC MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 102. CANADA ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2018-2030 (USD MILLION)
TABLE 103. CANADA ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2018-2030 (USD MILLION)
TABLE 104. CANADA ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2018-2030 (USD MILLION)
TABLE 105. CANADA ESTERS ANESTHETIC MARKET SIZE, BY CHEMICAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 106. MEXICO ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 107. MEXICO ESTERS ANESTHETIC MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 108. MEXICO ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 109. MEXICO ESTERS ANESTHETIC MARKET SIZE, BY SODIUM CHANNEL INHIBITION, 2018-2030 (USD MILLION)
TABLE 110. MEXICO ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. MEXICO ESTERS ANESTHETIC MARKET SIZE, BY DENTAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 112. MEXICO ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 113. MEXICO ESTERS ANESTHETIC MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 114. MEXICO ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2018-2030 (USD MILLION)
TABLE 115. MEXICO ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2018-2030 (USD MILLION)
TABLE 116. MEXICO ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2018-2030 (USD MILLION)
TABLE 117. MEXICO ESTERS ANESTHETIC MARKET SIZE, BY CHEMICAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES ESTERS ANESTHETIC MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES ESTERS ANESTHETIC MARKET SIZE, BY SODIUM CHANNEL INHIBITION, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES ESTERS ANESTHETIC MARKET SIZE, BY DENTAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES ESTERS ANESTHETIC MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES ESTERS ANESTHETIC MARKET SIZE, BY CHEMICAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES ESTERS ANESTHETIC MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 132. ASIA-PACIFIC ESTERS ANESTHETIC MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 134. ASIA-PACIFIC ESTERS ANESTHETIC MARKET SIZE, BY SODIUM CHANNEL INHIBITION, 2018-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. ASIA-PACIFIC ESTERS ANESTHETIC MARKET SIZE, BY DENTAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC ESTERS ANESTHETIC MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC ESTERS ANESTHETIC MARKET SIZE, BY CHEMICAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC ESTERS ANESTHETIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 144. AUSTRALIA ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 145. AUSTRALIA ESTERS ANESTHETIC MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 146. AUSTRALIA ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 147. AUSTRALIA ESTERS ANESTHETIC MARKET SIZE, BY SODIUM CHANNEL INHIBITION, 2018-2030 (USD MILLION)
TABLE 148. AUSTRALIA ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. AUSTRALIA ESTERS ANESTHETIC MARKET SIZE, BY DENTAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 150. AUSTRALIA ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 151. AUSTRALIA ESTERS ANESTHETIC MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 152. AUSTRALIA ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2018-2030 (USD MILLION)
TABLE 153. AUSTRALIA ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA ESTERS ANESTHETIC MARKET SIZE, BY CHEMICAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 156. CHINA ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 157. CHINA ESTERS ANESTHETIC MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 158. CHINA ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 159. CHINA ESTERS ANESTHETIC MARKET SIZE, BY SODIUM CHANNEL INHIBITION, 2018-2030 (USD MILLION)
TABLE 160. CHINA ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. CHINA ESTERS ANESTHETIC MARKET SIZE, BY DENTAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 162. CHINA ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 163. CHINA ESTERS ANESTHETIC MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 164. CHINA ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2018-2030 (USD MILLION)
TABLE 165. CHINA ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2018-2030 (USD MILLION)
TABLE 166. CHINA ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2018-2030 (USD MILLION)
TABLE 167. CHINA ESTERS ANESTHETIC MARKET SIZE, BY CHEMICAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 168. INDIA ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 169. INDIA ESTERS ANESTHETIC MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 170. INDIA ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 171. INDIA ESTERS ANESTHETIC MARKET SIZE, BY SODIUM CHANNEL INHIBITION, 2018-2030 (USD MILLION)
TABLE 172. INDIA ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. INDIA ESTERS ANESTHETIC MARKET SIZE, BY DENTAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 174. INDIA ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 175. INDIA ESTERS ANESTHETIC MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 176. INDIA ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2018-2030 (USD MILLION)
TABLE 177. INDIA ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2018-2030 (USD MILLION)
TABLE 178. INDIA ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2018-2030 (USD MILLION)
TABLE 179. INDIA ESTERS ANESTHETIC MARKET SIZE, BY CHEMICAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 180. INDONESIA ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 181. INDONESIA ESTERS ANESTHETIC MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 182. INDONESIA ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 183. INDONESIA ESTERS ANESTHETIC MARKET SIZE, BY SODIUM CHANNEL INHIBITION, 2018-2030 (USD MILLION)
TABLE 184. INDONESIA ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. INDONESIA ESTERS ANESTHETIC MARKET SIZE, BY DENTAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 186. INDONESIA ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 187. INDONESIA ESTERS ANESTHETIC MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 188. INDONESIA ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2018-2030 (USD MILLION)
TABLE 189. INDONESIA ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2018-2030 (USD MILLION)
TABLE 190. INDONESIA ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2018-2030 (USD MILLION)
TABLE 191. INDONESIA ESTERS ANESTHETIC MARKET SIZE, BY CHEMICAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 192. JAPAN ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 193. JAPAN ESTERS ANESTHETIC MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 194. JAPAN ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 195. JAPAN ESTERS ANESTHETIC MARKET SIZE, BY SODIUM CHANNEL INHIBITION, 2018-2030 (USD MILLION)
TABLE 196. JAPAN ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. JAPAN ESTERS ANESTHETIC MARKET SIZE, BY DENTAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 198. JAPAN ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 199. JAPAN ESTERS ANESTHETIC MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 200. JAPAN ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2018-2030 (USD MILLION)
TABLE 201. JAPAN ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2018-2030 (USD MILLION)
TABLE 202. JAPAN ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2018-2030 (USD MILLION)
TABLE 203. JAPAN ESTERS ANESTHETIC MARKET SIZE, BY CHEMICAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 204. MALAYSIA ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 205. MALAYSIA ESTERS ANESTHETIC MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 206. MALAYSIA ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 207. MALAYSIA ESTERS ANESTHETIC MARKET SIZE, BY SODIUM CHANNEL INHIBITION, 2018-2030 (USD MILLION)
TABLE 208. MALAYSIA ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. MALAYSIA ESTERS ANESTHETIC MARKET SIZE, BY DENTAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 210. MALAYSIA ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 211. MALAYSIA ESTERS ANESTHETIC MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 212. MALAYSIA ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2018-2030 (USD MILLION)
TABLE 213. MALAYSIA ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA ESTERS ANESTHETIC MARKET SIZE, BY CHEMICAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 216. PHILIPPINES ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 217. PHILIPPINES ESTERS ANESTHETIC MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 218. PHILIPPINES ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 219. PHILIPPINES ESTERS ANESTHETIC MARKET SIZE, BY SODIUM CHANNEL INHIBITION, 2018-2030 (USD MILLION)
TABLE 220. PHILIPPINES ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. PHILIPPINES ESTERS ANESTHETIC MARKET SIZE, BY DENTAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 222. PHILIPPINES ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 223. PHILIPPINES ESTERS ANESTHETIC MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 224. PHILIPPINES ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2018-2030 (USD MILLION)
TABLE 225. PHILIPPINES ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2018-2030 (USD MILLION)
TABLE 226. PHILIPPINES ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2018-2030 (USD MILLION)
TABLE 227. PHILIPPINES ESTERS ANESTHETIC MARKET SIZE, BY CHEMICAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 228. SINGAPORE ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 229. SINGAPORE ESTERS ANESTHETIC MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 230. SINGAPORE ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 231. SINGAPORE ESTERS ANESTHETIC MARKET SIZE, BY SODIUM CHANNEL INHIBITION, 2018-2030 (USD MILLION)
TABLE 232. SINGAPORE ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. SINGAPORE ESTERS ANESTHETIC MARKET SIZE, BY DENTAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 234. SINGAPORE ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 235. SINGAPORE ESTERS ANESTHETIC MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 236. SINGAPORE ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2018-2030 (USD MILLION)
TABLE 237. SINGAPORE ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2018-2030 (USD MILLION)
TABLE 238. SINGAPORE ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2018-2030 (USD MILLION)
TABLE 239. SINGAPORE ESTERS ANESTHETIC MARKET SIZE, BY CHEMICAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 240. SOUTH KOREA ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 241. SOUTH KOREA ESTERS ANESTHETIC MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 242. SOUTH KOREA ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 243. SOUTH KOREA ESTERS ANESTHETIC MARKET SIZE, BY SODIUM CHANNEL INHIBITION, 2018-2030 (USD MILLION)
TABLE 244. SOUTH KOREA ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. SOUTH KOREA ESTERS ANESTHETIC MARKET SIZE, BY DENTAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 246. SOUTH KOREA ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 247. SOUTH KOREA ESTERS ANESTHETIC MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 248. SOUTH KOREA ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2018-2030 (USD MILLION)
TABLE 249. SOUTH KOREA ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2018-2030 (USD MILLION)
TABLE 250. SOUTH KOREA ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2018-2030 (USD MILLION)
TABLE 251. SOUTH KOREA ESTERS ANESTHETIC MARKET SIZE, BY CHEMICAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 252. TAIWAN ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 253. TAIWAN ESTERS ANESTHETIC MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 254. TAIWAN ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 255. TAIWAN ESTERS ANESTHETIC MARKET SIZE, BY SODIUM CHANNEL INHIBITION, 2018-2030 (USD MILLION)
TABLE 256. TAIWAN ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. TAIWAN ESTERS ANESTHETIC MARKET SIZE, BY DENTAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 258. TAIWAN ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 259. TAIWAN ESTERS ANESTHETIC MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 260. TAIWAN ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2018-2030 (USD MILLION)
TABLE 261. TAIWAN ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2018-2030 (USD MILLION)
TABLE 262. TAIWAN ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2018-2030 (USD MILLION)
TABLE 263. TAIWAN ESTERS ANESTHETIC MARKET SIZE, BY CHEMICAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 264. THAILAND ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 265. THAILAND ESTERS ANESTHETIC MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 266. THAILAND ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 267. THAILAND ESTERS ANESTHETIC MARKET SIZE, BY SODIUM CHANNEL INHIBITION, 2018-2030 (USD MILLION)
TABLE 268. THAILAND ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. THAILAND ESTERS ANESTHETIC MARKET SIZE, BY DENTAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 270. THAILAND ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 271. THAILAND ESTERS ANESTHETIC MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 272. THAILAND ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2018-2030 (USD MILLION)
TABLE 273. THAILAND ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2018-2030 (USD MILLION)
TABLE 274. THAILAND ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2018-2030 (USD MILLION)
TABLE 275. THAILAND ESTERS ANESTHETIC MARKET SIZE, BY CHEMICAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 276. VIETNAM ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 277. VIETNAM ESTERS ANESTHETIC MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 278. VIETNAM ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 279. VIETNAM ESTERS ANESTHETIC MARKET SIZE, BY SODIUM CHANNEL INHIBITION, 2018-2030 (USD MILLION)
TABLE 280. VIETNAM ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. VIETNAM ESTERS ANESTHETIC MARKET SIZE, BY DENTAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 282. VIETNAM ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 283. VIETNAM ESTERS ANESTHETIC MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 284. VIETNAM ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2018-2030 (USD MILLION)
TABLE 285. VIETNAM ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2018-2030 (USD MILLION)
TABLE 286. VIETNAM ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2018-2030 (USD MILLION)
TABLE 287. VIETNAM ESTERS ANESTHETIC MARKET SIZE, BY CHEMICAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA ESTERS ANESTHETIC MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA ESTERS ANESTHETIC MARKET SIZE, BY SODIUM CHANNEL INHIBITION, 2018-2030 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA ESTERS ANESTHETIC MARKET SIZE, BY DENTAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA ESTERS ANESTHETIC MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2018-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2018-2030 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2018-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA ESTERS ANESTHETIC MARKET SIZE, BY CHEMICAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA ESTERS ANESTHETIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 301. DENMARK ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 302. DENMARK ESTERS ANESTHETIC MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 303. DENMARK ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 304. DENMARK ESTERS ANESTHETIC MARKET SIZE, BY SODIUM CHANNEL INHIBITION, 2018-2030 (USD MILLION)
TABLE 305. DENMARK ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. DENMARK ESTERS ANESTHETIC MARKET SIZE, BY DENTAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 307. DENMARK ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 308. DENMARK ESTERS ANESTHETIC MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 309. DENMARK ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2018-2030 (USD MILLION)
TABLE 310. DENMARK ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2018-2030 (USD MILLION)
TABLE 311. DENMARK ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2018-2030 (USD MILLION)
TABLE 312. DENMARK ESTERS ANESTHETIC MARKET SIZE, BY CHEMICAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 313. EGYPT ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 314. EGYPT ESTERS ANESTHETIC MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 315. EGYPT ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 316. EGYPT ESTERS ANESTHETIC MARKET SIZE, BY SODIUM CHANNEL INHIBITION, 2018-2030 (USD MILLION)
TABLE 317. EGYPT ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 318. EGYPT ESTERS ANESTHETIC MARKET SIZE, BY DENTAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 319. EGYPT ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 320. EGYPT ESTERS ANESTHETIC MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 321. EGYPT ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2018-2030 (USD MILLION)
TABLE 322. EGYPT ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2018-2030 (USD MILLION)
TABLE 323. EGYPT ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2018-2030 (USD MILLION)
TABLE 324. EGYPT ESTERS ANESTHETIC MARKET SIZE, BY CHEMICAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 325. FINLAND ESTERS ANESTHETIC MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 326. FINLAND ESTERS ANESTHETIC MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 327. FINLAND ESTERS ANESTHETIC MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 328. FINLAND ESTERS ANESTHETIC MARKET SIZE, BY SODIUM CHANNEL INHIBITION, 2018-2030 (USD MILLION)
TABLE 329. FINLAND ESTERS ANESTHETIC MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 330. FINLAND ESTERS ANESTHETIC MARKET SIZE, BY DENTAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 331. FINLAND ESTERS ANESTHETIC MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 332. FINLAND ESTERS ANESTHETIC MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 333. FINLAND ESTERS ANESTHETIC MARKET SIZE, BY HEALTHCARE SETTING, 2018-2030 (USD MILLION)
TABLE 334. FINLAND ESTERS ANESTHETIC MARKET SIZE, BY PROCEDURE COMPLEXITY, 2018-2030 (USD MILLION)
TABLE 335. FINLAND ESTERS ANESTHETIC MARKET SIZE, BY SAFETY PROFILE, 2018-2030 (USD MILLION)
TABLE 336.

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Esters Anesthetic market report include:
  • 3M Company (Medical Division)
  • Abbott Laboratories
  • AstraZeneca plc
  • Baxter International Inc.
  • Bayer AG
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • CSL Limited
  • Drägerwerk AG & Co. KGaA
  • Edwards Lifesciences Corporation
  • Eli Lilly and Company
  • GE Healthcare
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Medtronic plc
  • Merck & Co.
  • Mindray Medical International Limited
  • Novartis International AG
  • Olympus Corporation (Medical Division)
  • Pfizer Inc.
  • Philips Healthcare (Royal Philips)
  • Regeneron Pharmaceuticals, Inc.
  • ResMed Inc.
  • Roche Holding AG
  • Sanofi S.A.
  • Siemens Healthineers
  • Stryker Corporation
  • Terumo Corporation
  • Zimmer Biomet Holdings, Inc.

Related Topics

Related Reports

Dental Anesthetics Market by Anesthetic Type (General Anesthetics, Local Anesthetics, Sedation Agents), Route of Administration (Inhalation, Injectable, Topical), Application, End User, Distribution Channel, Patient Age Group - Global Forecast 2025-2030 - Product Image

Dental Anesthetics Market by Anesthetic Type (General Anesthetics, Local Anesthetics, Sedation Agents), Route of Administration (Inhalation, Injectable, Topical), Application, End User, Distribution Channel, Patient Age Group - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Anesthetic Drugs Market by Drug Type (General Anesthetics, Local Anesthetics), Administration Route (Inhalation, Intramuscular, Intravenous), Duration of Action, Application, End User - Global Forecast 2025-2030 - Product Image

Anesthetic Drugs Market by Drug Type (General Anesthetics, Local Anesthetics), Administration Route (Inhalation, Intramuscular, Intravenous), Duration of Action, Application, End User - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Local Anesthesia Drugs Market by Route Administration (Infiltration, Nerve Block, Regional), Drug Class (Amides, Esters), Product Type, Formulation, End-User, Distribution Channel, Application - Global Forecast 2025-2030 - Product Image

Local Anesthesia Drugs Market by Route Administration (Infiltration, Nerve Block, Regional), Drug Class (Amides, Esters), Product Type, Formulation, End-User, Distribution Channel, Application - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Anesthetics Market Report 2025 - Product Image

Anesthetics Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Local Anesthesia Drugs - Global Strategic Business Report - Product Image

Local Anesthesia Drugs - Global Strategic Business Report

  • Report
  • 283 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.